Surgery for Obesity and Related Diseases
Volume 4, Issue 3 , Pages 423-429 , May 2008

Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese

Presented at Annual Meeting of the American Society for Bariatric Surgeons, June 11 to June 16, 2007, San Diego, California

  • Anthony Brancatisano, B.Appl.Sc., M.B.B.S., Ph.D.

      Affiliations

    • Institute of Weight Control, Sydney, Australia
    • Corresponding Author InformationReprint requests: Dr Anthony Brancatisano, Institute of Weight Control, 495 Windsor Road, Baulkham Hills, Sydney, NSW 2153, Australia.
    • ,
  • Sara Wahlroos, B.Med.Sc.

      Affiliations

    • Institute of Weight Control, Sydney, Australia
    • ,
  • Slade Matthews, B.Med.Sc., Dip.Ed., Ph.D.

      Affiliations

    • Bosch Institute of Medical Research, University of Sydney, Sydney, Australia
    • ,
  • Roy Brancatisano, M.B.B.S.

      Affiliations

    • Institute of Weight Control, Sydney, Australia

Received 14 May 2007 ,Revised 22 July 2007 ,Accepted 24 October 2007.

References 

  1. O'Brien K, Webbie K. Health, well being and body weight: characteristics of overweight and obesity in Australia, 2001. Australian Institute of Health and Welfare. 2004;Cat. No. AUS 43, Bulletin No. 13
  2. National Health and Medical Research Council. Clinical Practice Guidelines for the management of overweight and obesity in adults. In: Canberra ACT, Australia: National Health and Medical Research Council; 2003;p. 1–265
  3. Cameron AJ, Welbourn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999–12000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;178:427–432
  4. Grundy SM. Does the metabolic syndrome exist?. Diabetes Care. 2006;29:1689–1692
  5. Wing R, Koeske R, Epstein I, et al. Long-term effects of modest weight loss in type 2 diabetic patients. Arch Intern Med. 1987;147:1749–1753
  6. Lean ME, Powrie JK, Anderson AS, et al. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med. 1990;7:228–233
  7. Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among over-weight individuals with diabetes. Diabetes Care. 2000;23:1499–1504
  8. Kundlacek S, Schernthaner G. The effect of insulin treatment on HbA1c, body weight and lipids in type 2 diabetic patients with secondary failure to sulfonylureas. Horm Metab Res. 1992;24:478–483
  9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737
  10. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? (An operation proves to be the most effective therapy for adult-onset diabetes mellitus). Ann Surg. 1995;222:339–352
  11. Cadiere GB, Bruyns J, Himpens J, Favretti F. Laparoscopic gastroplasty for morbid obesity. Br J Surg. 1994;81:1524
  12. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement—executive summary. Circulation. 2005;112:e285–e290
  13. Ware J. Validity norm-based interpretation. In: SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Centre; 1997;p. 10.1–10.38
  14. Cash T. Multidimensional body-self relations questionnaire: MBSRQ user's manual. Norfolk, VA: Old Dominion University; 1994;
  15. Dixon JB, O'Brien PE. Health outcomes on severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25:358–362
  16. Dolan K, Bryant R, Fielding G. Treating diabetes in the morbidly obese by laparoscopic gastric banding. Obes Surg. 2003;13:439–443
  17. Ponce J, Haynes B, Paynter S, et al. Effect of Lap-Band® induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg. 2004;14:1335–1342
  18. Sjöstrom L, Lindroos A, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–2753
  19. Pontiroli AE, Vedani P, Folli F, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity. Diabetes Care. 2005;28:2703–2709
  20. Camastra S, Frascerra S, Manco M, et al. β-Cell function in severely obese type 2 diabetic patients. Diabetes Care. 2007;30:1002–1004
  21. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  22. Bryant W, Greenfield JR, Chisholm DJ, et al. Diabetes guidelines: easier to preach than to practice? (A retrospective audit of out patient management of type 1 and type 2 diabetes mellitus). MJA. 2006;185:305–309
  23. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in γ-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16:1278–1286
  24. Sjöstrom CD, Lissner L, Wedel H, et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obes Res. 1999;7:477–484
  25. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or and intensive medical program: a randomized trial. Ann Intern Med. 2006;144:625–634
  26. Rubin PR, Peyrot M. Psychosocial problems and intervention in diabetes. Diabetic Care. 1992;15:1640–1657
  27. Lloyd CE, Matthews KA, Wing RR, et al. Psychosocial factors and complications of IDDM. Diabetes Care. 1992;15:166–172
  28. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934–942

 This research was supported by a grant from Johnson & Johnson Medical, the manufacturer of the Swedish adjustable gastric band.

PII: S1550-7289(07)00708-3

doi: 10.1016/j.soard.2007.10.011

Surgery for Obesity and Related Diseases
Volume 4, Issue 3 , Pages 423-429 , May 2008

Article Tools